Traduction de «access to cancer » (Néerlandais → Français) :

All-round Semi-cellular Trunking Radio communication system with Integrated Dispatchings Code Division Multiple Access Digital Audio Broadcasting - Terrestrial Digital Enhanced Cordless Telecommunications Elektrisch veld Elektro-encephalogram Extremely Low Frequency Electromagnetic Field Global System for Mobile Communications Hyper Local Area Network International Agency for Research on Cancer International Commission on Non-Ionizing Radiation Protection Magnetic Resonance Imaging Positron Emission Tomography Power Spectral Density Radio Frequentie Specific Absorption Rate Single photon emission computed tomography Time Division Multiplexing Time Division Mutiple Access Universal Mobile Communication Systems Ultra Wideband Wireless Fidelity Wordwide Interoperability for Microwave Access Wireless Local Area Network
All-round Semi-cellular Trunking Radio communication system with Integrated Dispatchings Code Division Multiple Access Digital Audio Broadcasting – Terrestrial Digital Enhanced Cordless Telecommunications Champ électrique Electro-encéphalogramme Extremely Low Frequency Electromagnetic Field Global System for Mobile Communications Hyper Local Area Network International Agency for Research on Cancer International Commission on Non-Ionizing Radiation Protection Imagerie par résonance magnétique Positron Emission Tomography Power Spectral Density Radio Fréquence Specific Absorption Rate Single photon emission computed tomography Time Division Multiplexing Time Division Mutiple Access Universal Mobile Communication Systems Ultra Wideband Wireless Fidelity Wordwide Interoperability for Microwave Access Wireless Local Area Network

Expanding access to cancer screening and clinical follow-up among the medically underserved.
Expanding access to can- cer screening and clinical follow-up among the medically

Figuur III. 4. verkoop van kankergeneesmiddelen in Europa (bron Corporate Report on Patiens Access to cancer drugs in Europe” van het Karolinska Institute, Stockholm Sweden (jan 2009))
Schéma III. 4. Vente de médicaments anti-cancer en Europe (Source : “Corporate Report on Patients Access to cancer drugs in Europe”, Karolinska Institutet, Stockholm, Suède (jan 2009))

(**) Corporate Report on Patiens Access to cancer drugs in Europe” van het Karolinska Institute, Stockholm Sweden (jan 2009)
(**) “Corporate Report on Patients Access to cancer drugs in Europe”, Karolinska Institute, Stockholm, Suède (janvier 2009)